HLB bioStepLtd Balance Sheet Health
Financial Health criteria checks 4/6
HLB bioStepLtd has a total shareholder equity of ₩128.6B and total debt of ₩32.1B, which brings its debt-to-equity ratio to 25%. Its total assets and total liabilities are ₩170.2B and ₩41.5B respectively.
Key information
25.0%
Debt to equity ratio
₩32.12b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩51.73b |
| Equity | ₩128.62b |
| Total liabilities | ₩41.54b |
| Total assets | ₩170.16b |
Recent financial health updates
Here's Why HLB bioStepLtd (KOSDAQ:278650) Has A Meaningful Debt Burden
Feb 28
Is KNOTUSLtd (KOSDAQ:278650) Using Too Much Debt?
Feb 03
Recent updates
HLB bioStep Co.,Ltd. (KOSDAQ:278650) Shares May Have Slumped 33% But Getting In Cheap Is Still Unlikely
May 22Subdued Growth No Barrier To HLB bioStep Co.,Ltd. (KOSDAQ:278650) With Shares Advancing 29%
Mar 29Here's Why HLB bioStepLtd (KOSDAQ:278650) Has A Meaningful Debt Burden
Feb 28With EPS Growth And More, KNOTUSLtd (KOSDAQ:278650) Is Interesting
Mar 17What Kind Of Investors Own Most Of KNOTUS Co.,Ltd (KOSDAQ:278650)?
Feb 24Is KNOTUSLtd (KOSDAQ:278650) Using Too Much Debt?
Feb 03Investors Who Bought KNOTUSLtd (KOSDAQ:278650) Shares A Year Ago Are Now Up 26%
Jan 13Should We Be Delighted With KNOTUS Co.,Ltd's (KOSDAQ:278650) ROE Of 15%?
Dec 23Is Now The Time To Put KNOTUSLtd (KOSDAQ:278650) On Your Watchlist?
Dec 02Financial Position Analysis
Short Term Liabilities: A278650's short term assets (₩61.3B) exceed its short term liabilities (₩37.1B).
Long Term Liabilities: A278650's short term assets (₩61.3B) exceed its long term liabilities (₩4.4B).
Debt to Equity History and Analysis
Debt Level: A278650 has more cash than its total debt.
Reducing Debt: A278650's debt to equity ratio has reduced from 36.1% to 25% over the past 5 years.
Debt Coverage: A278650's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if A278650's interest payments on its debt are well covered by EBIT.